228 related articles for article (PubMed ID: 29272498)
1. Current status and future prospects for disease modification in osteoarthritis.
Huang Z; Ding C; Li T; Yu SP
Rheumatology (Oxford); 2018 May; 57(suppl_4):iv108-iv123. PubMed ID: 29272498
[TBL] [Abstract][Full Text] [Related]
2. Current Treatment Options for Osteoarthritis.
Hermann W; Lambova S; Muller-Ladner U
Curr Rheumatol Rev; 2018; 14(2):108-116. PubMed ID: 28875826
[TBL] [Abstract][Full Text] [Related]
3. Prospects for disease modification in osteoarthritis.
Abramson SB; Attur M; Yazici Y
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):304-12. PubMed ID: 16932709
[TBL] [Abstract][Full Text] [Related]
4. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis.
Pelletier JP
Osteoarthritis Cartilage; 2004; 12 Suppl A():S63-8. PubMed ID: 14698646
[TBL] [Abstract][Full Text] [Related]
5. Investigational drugs for the treatment of osteoarthritis, an update on recent developments.
Zhu Z; Li J; Ruan G; Wang G; Huang C; Ding C
Expert Opin Investig Drugs; 2018 Nov; 27(11):881-900. PubMed ID: 30345826
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic therapy for osteoarthritis--the era of disease modification.
Hunter DJ
Nat Rev Rheumatol; 2011 Jan; 7(1):13-22. PubMed ID: 21079644
[TBL] [Abstract][Full Text] [Related]
7. The disease-modifying effect of dehydroepiandrosterone in different stages of experimentally induced osteoarthritis: a histomorphometric study.
Huang K; Bao JP; Jennings GJ; Wu LD
BMC Musculoskelet Disord; 2015 Jul; 16():178. PubMed ID: 26228537
[TBL] [Abstract][Full Text] [Related]
8. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
Oo WM; Yu SP; Daniel MS; Hunter DJ
Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
[TBL] [Abstract][Full Text] [Related]
9. OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?
Hellio Le Graverand-Gastineau MP
Osteoarthritis Cartilage; 2009 Nov; 17(11):1393-401. PubMed ID: 19426849
[TBL] [Abstract][Full Text] [Related]
10. Osteoarthritis 2: pain management and treatment strategies.
Swift A
Nurs Times; 2012 Feb 21-27; 108(8):25-7. PubMed ID: 22458083
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.
TenBroek EM; Yunker L; Nies MF; Bendele AM
Arthritis Res Ther; 2016 Jan; 18():24. PubMed ID: 26794830
[TBL] [Abstract][Full Text] [Related]
12. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
[TBL] [Abstract][Full Text] [Related]
13. Prospects of Disease-Modifying Osteoarthritis Drugs.
Oo WM
Rheum Dis Clin North Am; 2024 Aug; 50(3):483-518. PubMed ID: 38942581
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity.
Goldberg VM; Buckwalter JA
Osteoarthritis Cartilage; 2005 Mar; 13(3):216-24. PubMed ID: 15727888
[TBL] [Abstract][Full Text] [Related]
15. Investigational drugs for the treatment of osteoarthritis.
Wang K; Xu J; Hunter DJ; Ding C
Expert Opin Investig Drugs; 2015; 24(12):1539-56. PubMed ID: 26429673
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for the treatment of knee osteoarthritis.
Yu SP; Hunter DJ
Expert Opin Emerg Drugs; 2015 Sep; 20(3):361-78. PubMed ID: 25865855
[TBL] [Abstract][Full Text] [Related]
17. Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
Siebuhr AS; Bay-Jensen AC; Jordan JM; Kjelgaard-Petersen CF; Christiansen C; Abramson SB; Attur M; Berenbaum F; Kraus V; Karsdal MA
Scand J Rheumatol; 2016; 45(2):87-98. PubMed ID: 26484849
[TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate, a promising disease modifying osteoarthritis drug.
Han W; Fan S; Bai X; Ding C
Expert Opin Investig Drugs; 2017 Mar; 26(3):375-380. PubMed ID: 28092725
[TBL] [Abstract][Full Text] [Related]
19. Prospects for Therapies in Osteoarthritis.
Ghouri A; Conaghan PG
Calcif Tissue Int; 2021 Sep; 109(3):339-350. PubMed ID: 32055890
[TBL] [Abstract][Full Text] [Related]
20. Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014.
Eckstein F; Le Graverand MP
Semin Arthritis Rheum; 2015 Dec; 45(3):251-6. PubMed ID: 26142321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
